double stranded helix structure. Other deduced mechanisms of tumor cell destruction of Daunorubicin include
inhibition of polymerase activity, down regulation of gene expression and generation of free radicals [6]. In an
animal study, Daunorubicin are observed to cause B-cells stimulation while T-cells are suppressed at a certain
concentration [7], therefore we propose that, in the background of pre-existing nodal cellular hyperplasia which
is often the case for reactive lymphadenitis to underlying chronic tonsillitis, B-cells were stimulated by
Daunorubicin and underwent unregulated hyperplasia, leading to ischemia in the core of the lymph nodes hence
forming the necrotic foci, further suppurative process may be due to presence of capsular neutrophils, which
liquefied necrotic tissue into pus, and subsequently spread extranodally into neck abscess.
Even though there is no positive culture result to demonstrate bacteria involvement, we still presumed the
presence of common upper respiratory tract bacteria in the process due to patient’s history of underlying chronic
tonsillitis, we are confident that our choice of early (and prolonged) empirical IV antibiotic has prevented a more
serious outcome such as septicemia and disseminated abscesses of various organs. Brito et al 2017, found the
most common primary foci which led to deep neck abscess among adults are the tonsils (31.68%), followed by
infected teeth (23.7%), while other less common primary foci are infected cervical lymph nodes, upper airway
mucosa and foreign bodies, meanwhile in a another 14.8%, no primary foci were found. The same study also
noted that Streptococcus species (pyogenes, pneumoniae, intermedius, viridans and contelattus) are the most
frequently isolated organism, followed by Staphylococci sp, Enterococci sp, Neisseria spp and Klebsiella sp [1][3]
.
Therefore empirical antibiotics that cover gram positive bacterias, particularly against streptococci are justified
and should be started earliest possible to prevent further complications such as mediastinitis, systemic sepsis,
Internal jugular vein thrombosis (Lemierre’s syndrome), carotid blowout and airway compromise [3].
CONCLUSION
Deep neck space infection is a condition that needs to be anticipated in any immunocompromised patient
presenting with acute cervical lymphadenitis, early empirical antibiotic and close surveillance should be the
mainstay strategy. In patients where deep neck abscesses have already developed, surgical approaches to drain
the abscesses should be well planned and individualized to ensure favorable outcome. As this case comes to
light, we hope similar conditions encountered will be reported globally, for case series or even retrospective
studies in the future will help to further refine practices of clinicians.
REFERENCE
1. Brito TP, Hazboun IM, Fernandes FL, Bento LR, Zappelini CEM, Chone CT, Crespo AN. Deep neck
abscesses: study of 101 cases. Braz J Otorhinolaryngol. 2017 May-Jun;83(3):341-348. doi:
10.1016/j.bjorl.2016.04.004. Epub 2016 May 5. PMID: 27236632
2. Pradnyani, I. Gusti Agung Sri, et al. “Oral Manifestations of Acute Myeloid Leukemia: A Case Series.”
3. Rzepakowska A, Rytel A, Krawczyk P, Osuch-Wójcikiewicz E, Widłak I, Deja M, Niemczyk K. The
Factors Contributing to Efficiency in Surgical Management of Purulent Infections of Deep Neck Spaces.
Ear Nose Throat J. 2021 Jun;100(5):354-359. doi: 10.1177/0145561319877281. Epub 2019 Sep 29.
PMID: 31565988.
4. Staffieri, C, Fasanaro, E, Favaretto, N, et al. Multivariate approach to investigating prognostic factors in
deep neck infections. Eur Arch Otorhinolaryngol. 2014;271(7):2061–2067
5. Sheibani K, Fritz RM, Winberg CD, Burke JS, Rappaport H. "Monocytoid" cells in reactive follicular
hyperplasia with and without multifocal histiocytic reactions: an immunohistochemical study of 21 cases
including suspected cases of toxoplasmic lymphadenitis. American Journal of Clinical Pathology. 1984
Apr;81(4):453-458. DOI: 10.1093/ajcp/81.4.453. PMID: 6702746.
6. Fukushima T, Ueda T, Uchida M, Nakamura T. Action mechanism of idarubicin (4-
demethoxydaunorubicin) as compared with daunorubicin in leukemic cells. International Journal of
Hematology. 1993 Apr;57(2):121-130. PMID: 8494991.
7. Orsini FR, Henderson ES. Doxorubicin and daunorubicin modulation of macrophages, T and B
lymphocytes (anthracycline lymphocyte modulation). Immunopharmacology. 1980 Dec;2(4):375-84.
doi: 10.1016/0162-3109(80)90021-1. PMID: 6970189.
Page 1472